Ali H AlWadei
Overview
Explore the profile of Ali H AlWadei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
AlKadhem S, Alradhi A, AlJubab H, AlWadei A
Cureus
. 2024 Dec;
16(11):e74492.
PMID: 39726451
Guillain-Barré syndrome (GBS) is an acute immune-mediated polyneuropathy with diverse clinical presentations. Mycoplasma pneumoniae has been increasingly recognized as a potential trigger, particularly in pediatric cases. This case report presents...
2.
Aljthalin R, Albalawi R, AlWadei A, Aljthalin A
Neurosciences (Riyadh)
. 2024 Oct;
29(4):288-291.
PMID: 39379093
Moyamoya disease is an idiopathic chronic and progressive vaso-occlusive disease ofthe bilateral intracranial branches of the internal carotid artery. Growth hormone failure, thyroid dysfunction, and low cortisol hormones are consequences...
3.
Kentab A, Alsalloum Y, Labani M, Hudairi A, Hamad M, Jamjoom D, et al.
Front Pediatr
. 2024 May;
12:1377515.
PMID: 38745833
Background: Brown-Vialetto-Van Laere (BVVL) syndrome is an extremely rare autosomal recessive progressive motoneuron disease that is caused by a defect in the riboflavin transporter genes SLC52A2 and SLC52A3. BVVL syndrome...
4.
Saleh M, Hamhom A, Al-Otaibi A, Alghamdi M, Housawi Y, Aljadhai Y, et al.
Pediatr Neurol
. 2024 Apr;
155:149-155.
PMID: 38653183
Background: Neuronal ceroid lipofuscinoses (NCLs) represent a heterogeneous group of inherited metabolic lysosomal disorders characterized by neurodegeneration. This study sought to describe the clinical and molecular characteristics of NCLs in...
5.
AlHargan A, Almuhaizea M, Almass R, AlWadei A, Daghestani M, Arold S, et al.
Hum Genome Var
. 2023 Feb;
10(1):7.
PMID: 36810590
Compound heterozygous mutations in SHQ1 have been associated with a rare and severe neurological disorder characterized by global developmental delay (GDD), cerebellar degeneration coupled with seizures, and early-onset dystonia. Currently,...
6.
Bashiri F, Al Dosari A, Hamad M, Kentab A, AlWadei A
Int J Pediatr Adolesc Med
. 2022 Jun;
9(2):131-135.
PMID: 35663781
Purpose And Background: To evaluate the electro-clinical manifestations and outcomes of children with absence epilepsy at a tertiary center in Saudi Arabia. Methods: This retrospective study reviewed the medical and...
7.
Alanazi G, ALOsaimi T, AlWadei A, Al-Otaibi A, Jad L, Al-Attas A
Neurosciences (Riyadh)
. 2022 Apr;
27(2):59-64.
PMID: 35477916
Objectives: To compare the efficacy and safety of corpus callosotomy versus vagus nerve stimulation (VNS) as long-term adjunctive therapies in children with Lennox-Gastaut syndrome. Methods: This retrospective study was conducted...
8.
Scala M, Wortmann S, Kaya N, Stellingwerff M, Pistorio A, Glamuzina E, et al.
Hum Mutat
. 2022 Jan;
43(3):403-419.
PMID: 34989426
Developmental and epileptic encephalopathy 35 (DEE 35) is a severe neurological condition caused by biallelic variants in ITPA, encoding inosine triphosphate pyrophosphatase, an essential enzyme in purine metabolism. We delineate...
9.
Bashiri F, Al Johani S, Hamad M, Kentab A, AlWadei A, Hundallah K, et al.
Front Pediatr
. 2020 Nov;
8:526.
PMID: 33163461
Acute necrotizing encephalopathy of childhood (ANEC) is a rapidly progressing encephalopathy characterized by fever, depressed level of consciousness, and seizures. Diagnosis depends on clinical presentation and characteristic neuroimaging findings of...
10.
Clinical, molecular, and biochemical delineation of asparagine synthetase deficiency in Saudi cohort
Alharby E, Faqeih E, Saleh M, Alameer S, Almuntashri M, Pastore A, et al.
Genet Med
. 2020 Aug;
22(12):2071-2080.
PMID: 32741967
Purpose: Asparagine synthetase deficiency (ASNSD) is a rare neurometabolic disease. Patients may not demonstrate low asparagine levels, which highlights the advantage of molecular over biochemical testing in the initial work-up...